5 Results for "

human H4R

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "human H4R" in MCE Product Catalog:

Cat. No.: HY-16756
CAS No.: 952494-46-1
Synonyms: JNJ-38518168
Target:  

Histamine Receptor

Research Areas:  

Neurological Disease Endocrinology

Toreforant is a potent and selective histamine H4 receptor (H4R) antagonist, with a Ki at the human receptor of 8.4 nM.
loading...
    loading...
Cat. No.: HY-147276
CAS No.: 1429374-83-3
Purity:  98.88%
Synonyms: JW1601
Target:  

Histamine Receptor

Research Areas:  

Inflammation/Immunology

Izuforant (JW1601) (Compound 24) is an orally active histamine H4 receptor (H4R) antagonist with an IC50 of 36 nM against human H4R. Izuforant also shows binding affinity of human serotonin 3 receptor (h5-HT3R) with an IC50 of 9.1 μM. Izuforant exhibits strong anti-pruritic and anti-inflammatory efficacies .
loading...
    loading...
Cat. No.: HY-113936
CAS No.: 1027330-97-7
A-943931 is a potent and selective histamine H4 receptor (H4R) antagonist with pKi values of 4.6, 3.8 nM for human and rat H4R, respectively. A-943931 shows anti-inflammatory and antinociceptive efficacy .
loading...
    loading...
Cat. No.: HY-124912
CAS No.: 3455-10-5
Target:  

Histamine Receptor

Research Areas:  

Others

VUF-6884 (Compound 7j) is a histamine receptor (Histamine Receptor) ligand with activity toward human H4R and H1R. Its pEC50 and pKi values against human H4R are 7.70 and 7.55, respectively, while those against human H1R are 8.17 and 8.11, respectively. VUF-6884 competitively binds to the orthosteric binding site of human H4R to displace histamine, and exhibits inverse agonist activity at human H1R .
loading...
    loading...
Cat. No.: HY-114510
CAS No.: 1020399-52-3
PRMT/HKMT-IN-1 is an epigenetic multi-target protein arginine methyltransferases (PRMTs) and histone lysine methyltransferases (HKMTs) inhibitor. PRMT/HKMT-IN-1 inhibits Aspergillus nidulans RmtA with an IC50 of 29 μM. PRMT/HKMT-IN-1 inhibits human PRMT1, p300/CBP HAT, CARM1, SET7, SIRT1 and SIRT2. PRMT/HKMT-IN-1 inhibits methylation of histone H3K4, H4R3, and H3R17 residues. CBP/p300-IN-23 induces apoptosis, arrests cell cycle in S phase, and triggers granulocytic differentiation in leukemia cells. PRMT/HKMT-IN-1 can be used for the research of leukemia .
loading...
    loading...